| |
|
SHS Newsletter – To open this newsletter in your browser, please click here.
|
| |
|
|
|
| |
February 2021
|
 |
|
|
|
| |
| |
|
Dear Sir or Madam,
|
| |
Once again, we have interesting topics in store for you in this first SHS Newsletter of 2021.
Uwe Steinbacher and Manfred Ulmer-Weber offer a positive summary of a year none of us is likely to forget. Spoiler alert: 2020 was a very good year for SHS!
We report on the sale of Austria-based Single Use Support GmbH, a firm that is setting new standards in the field of worldwide liquid logistics for the healthcare sector.
Today, under the new heading, ‘Milestones in medical technology’, we present you with an innovation that was created at a kitchen table in Zurich and has already saved the lives of many people.
Network with us and learn all the important news from healthcare and SHS in real time. Our LinkedIn account also offers some information that is not found in the newsletter.
We wish you all the best for 2021!
Kind regards
|
| |
|
| |
|
Sascha Alilovic
|
|
|
|
| |
| |
|
Topics
|
| |
| • |
Impact investing and ESG: Impact-oriented investing in the healthcare sector
|
| |
|
|
| • |
2020 - Uwe Steinbacher and Manfred Ulmer-Weber take stock for SHS
|
| |
|
|
| • |
Medtech-INSIDE: The SHS column by Dr. André Zimmermann in medtech zwo
|
| |
|
|
|
| • |
Shares in Single Use Support GmbH, the Austria-based life science supplier, sold
|
| |
|
|
| • |
SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects
|
| |
|
|
| • |
Medtech specialist puracon GmbH sold to Klingel medical metal group
|
| |
|
|
| • |
Salvia receives Breakthrough Device Designation from American FDA
|
| |
|
|
| • |
CE approval for the world’s first digital dental implant by TRI Dental lmplants Int. AG
|
| |
|
|
| • |
Success for Selfapy: Online course to combat depression now available with a prescription
|
| |
|
|
| • |
Regulatory approval for the highly sensitive, high-speed coronavirus test system by GNA Biosolutions
|
| |
|
|
| • |
CARLO®, the surgical robot system by AOT, receives CE approval
|
| |
|
|
|
|
|
| • |
Experience for the future: Internships at SHS
|
| |
|
|
| • |
Milestones in medical technology
|
| |
|
|
| • |
Always informed: SHS on LinkedIn
|
| |
|
|
|
| • |
Jobs at Portfolio Companies
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Impact investing and ESG: Impact-oriented investing in the healthcare sector |
|
|
| |
| |
|
|
Impact investing on the rise. A conversation with Dr. André Zimmermann.
|
|
|
|
|
|
| |
| |
|
|
| |
2020 - Uwe Steinbacher and Manfred Ulmer-Weber take stock for SHS |
|
|
| |
| |
Uwe Steinbacher and Manfred Ulmer-Weber talk about an extraordinary year 2020 and draw a positive balance for SHS.
|
|
|
|
|
.jpeg "MUW_US") |
| |
| Manfred Ulmer Weber (left) and Uwe Steinbacher (right) during the video conference with the editorial team |
|
|
|
|
| |
| |
|
|
| |
Medtech-INSIDE: The SHS column by Dr. André Zimmermann in medtech zwo |
|
|
| |
| |
|
|
New: The monthly SHS column by Dr. André Zimmermann in medtech zwo.
|
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
Shares in Single Use Support GmbH, the Austria-based life science supplier, sold |
|
|
| |
| |
|
|
Successful exit for SHS: Single Use Support as a unit of Pall Corporation on the way to becoming the gold standard.
|
|
|
|
|
|
| |
| |
|
|
| |
SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects |
|
|
| |
| |
The intelligent drugs manufactured by our new investee Develco Pharma are making severe pain more tolerable for many patients.
|
|
|
|
|
|
|
|
| |
| |
|
|
| |
Medtech specialist puracon GmbH sold to Klingel medical metal group |
|
|
| |
| |
|
|
After five years, SHS sells puracon GmbH to Klingel medical metal group.
|
|
|
|
|
|
| |
| |
|
|
| |
Salvia receives Breakthrough Device Designation from American FDA |
|
|
| |
| |
Hope for migraine patients in the USA: Salvia receives Breakthrough Device Designation.
|
|
|
|
|
|
|
|
| |
| |
|
|
| |
CE approval for the world’s first digital dental implant by TRI Dental lmplants Int. AG |
|
|
| |
| |
|
|
matrix®, the CE-approved digital dental implant on its way to Europe.
|
|
|
|
|
|
| |
| |
|
|
| |
Success for Selfapy: Online course to combat depression now available with a prescription |
|
|
| |
| |
Selfapy offers the first app to combat depression, now available by prescription.
|
|
|
|
|
|
|
|
| |
| |
|
|
| |
Regulatory approval for the highly sensitive, high-speed coronavirus test system by GNA Biosolutions |
|
|
| |
| |
|
|
A result in 40 minutes: GNA receives official approval for SARS-CoV-2 test system.
|
|
|
|
|
|
| |
| |
|
|
| |
CARLO®, the surgical robot system by AOT, receives CE approval |
|
|
| |
| |
The first touchless device for laser surgery on human beings receives CE approval.
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
|
|
|
| |
| |
|
|
Our youngest team member, Katharina Kolenda.
|
|
|
|
|
|
| |
| |
|
|
| |
Experience for the future: Internships at SHS |
|
|
| |
| |
|
|
 |
| |
| SHS interns Vera Schlenker and Lukas Gromes |
|
|
|
|
| |
| |
|
|
| |
Milestones in medical technology |
|
|
| |
| |
.jpeg "Meilenstein_1") |
| |
| We thank the University Library of Zurich for the use of the photo. |
|
|
|
Did you know that the first balloon catheters for use in dilatation procedures on heart attack patients were made in a kitchen in Zurich?
|
|
|
|
|
|
| |
| |
|
|
| |
Always informed: SHS on LinkedIn |
|
|
| |
| |
Network with us and learn all the important news from healthcare and SHS in real time. Our LinkedIn account also offers some minor and major news that cannot be found in the newsletter. Link!
|
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
Jobs at Portfolio Companies |
|
|
| |
|
|
| |
| |
|
|
|
|
| |
| |
(Junior) Investment Manager (m/f/d)
Read more »
|
|
| |
Entrepreneur (m/f/d) wanted: Management Buy-in/Buy-out (MBI/MBO)
Read more »
|
|
| |
Private Equity & Venture Capital Internship
Read more »
|
|
|
| |
| |
|
|
|
|
|
|
|
| |
| |
ZDF heute Sendung, 29 December 2020: „New rapid test from Bavaria“ |
|
| |
ZDF TV reports in its heute Sendung (from min. 07:32) at prime time about our portfolio company GNA Biosolutions GmbH. The company has received emergency approval for its point-of-care test, which enables detection for COVID19 within 40 minutes. |
|
| |
Read more » |
|
|
| |
| |
Badische Zeitung, 19 December 2020: „SHS invests in Develco“ |
|
| |
The Badische Zeitung reports on SHS's investment in the Swiss-German specialty pharmaceuticals company Develco Pharma. |
|
| |
Read more » |
|
|
| |
| |
Unquote, 2 December 2021: „SHS sells puracon to IK-backed Klingel“ |
|
| |
Unquote reports on the sale of our portfolio company puracon to the precision machining business Klingel medical metal, which is a portfolio company of IK Investment Partners. |
|
| |
Read more » |
|
|
| |
| |
Plattform Life Sciences – Medizintechnik & Digital Health, November 2020: „We see ourselves as sector specialists“ |
|
| |
The trade magazine of going public portrays SHS (page 50-51) as one of the oldest players in the financing of German life sciences companies, start-ups and SMEs, with a focus on medical technology, diagnostics, suppliers and digital health. |
|
| |
Read more » |
|
|
| |
| |
|
|
| |
|
|
| |
Investment focus
|
|
| |
|
|
| |
| Sector: |
|
life sciences (medical technology, diagnostics, applied technologies, digital health, industrial biotechnology/pharmaceutical industry; no drug development) |
| Geographical Focus: |
|
Germany, Austria, Switzerland, Scandinavia, Benelux |
| Reasons for investment: |
|
growth capital, strengthening equity, MBO/MBI, change of shareholders/succession, M&A financing, spin-off |
| Company situation: |
|
growth/expansion, succession/company sale, internationalization; operating profit may be negative for growth, or for technology-related reasons |
| Transaction value and investment size: |
|
transaction value: up to € 100m; investment amount:
€ 2-30m, with a co-investor from the SHS-network up to € 60m |
| Investment types: |
|
majorities or minorities, equity & financial instruments similar to equity |
|
|
| |
|
|
|
|
|
| |
|
|
| |
The newsletter is published by SHS Gesellschaft für Beteiligungsmanagement mbH
|
|
| |
|
|
| |
Bismarckstrasse 12 | 72072 Tuebingen | Germany | www.shs-capital.eu
Tel +49 7071 9169-0 | Fax +49 7071 9169-190
|
|
| |
|
|
| |
|
Editorial team: SHS Gesellschaft für Beteiligungsmanagement mbH
Design and technical realisation: UNIBRAND GmbH
|
|
To unsubscribe the newsletter, please click here. If you like us to delete your data, please send an email with the subject „data deletion“ to tuebingen@shs-capital.eu.
|
|
|
| |
|
|
|
|
| |
|
.jpeg "Krankenschwester_2")
.jpeg "AZ_medtech")
.jpeg "SUS")
.jpeg "PUR_PM")
.jpeg "SAL_Logo")
.jpeg "TRI")
.jpeg "Selfapy")
.jpeg "AOT_Carlo")
.jpeg "KKO.jpg")
.jpeg "LinkedIn-Logo_.png")